A phase I and II study of 2-weekly irinotecan with capecitabine in advanced gastroesophageal adenocarcinoma.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/6DF887EC.svg?ark=w1%2F20260515%2F6DF887EC)](https://nobleid.org/work/w1/20260515/6DF887EC)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors